Yong Wang, Peng Daizhi, Wang Lihua, Dong Zhengxue, He Bing
Institute of Burn Research, State Key Laboratory of Trauma, Burns and Combined Injury, Southwest Hospital, Third Military Medical University, Chongqing, China (mainland).
Med Sci Monit Basic Res. 2015 Feb 12;21:21-8. doi: 10.12659/MSMBR.893143.
Inhibition of CC chemokine ligand 20 (CCL20), which is expressed by human keratinocytes after proinflammatory cytokine stimulation, may reduce migration of recipient Langerhans cells into tissue-engineered allogeneic skin grafts and minimize immune rejection by the recipient. Here, we screened CCL20 gene knockout clones in the human immortalized skin keratinocyte line HaCaT and tested multiple transfection methods for optimal efficiency.
The CCL20 gene was PCR amplified from HaCaT genomic DNA. Both the short arm (1,969 bp) and long arm (2,356 bp) of human CCL20 were cloned into ploxP-targeting vectors at either side of the neomycin resistance cassette, respectively. The resulting ploxP-hCCL20-targeting vector was linearized and electroporated into HaCaT. The positive HaCaT clones were screened under the pressure of both G418 and GANC, and identified by PCR and Southern blot. The ploxP-hCCL20-EGFP fluorescent expression vector was also constructed and transfected into 293FT and HaCaT cells by jetPEI liposome and nucleofection electroporation for evaluating the transfect efficiency under fluorescent microscope.
The replacement targeting vector ploxP-hCCL20 (11.9 kb) for exon 2 of the human CCL20 gene was successfully constructed and transfected into HaCaT cells. The selected HaCaT clones did not show any evidence of CCL20 gene knockout by either PCR or Southern blot analysis. We also successfully constructed a fluorescent expression vector ploxP-hCCL20-EGFP (13.3 kb) to assess possible reasons for gene-targeting failure. Transfection efficiencies of ploxP-hCCL20-EGFP into 293FT and HaCaT cell lines by jetPEI liposome were 75.1 ± 3.4% and 1.3 ± 0.2%, respectively. The transfection efficiency of ploxP-hCCL20-EGFP into HaCaT cells using nucleofection electroporation was 0.3±0.1% (P=0.000), but the positive control vector pmaxGFP (3,490 bp) using the same method was 38.3 ± 2.8%.
Overall low transfection efficiencies of ploxP-hCCL20-EGFP into HaCaT cells, regardless of transfection method, may either be due to the high molecular weight of the vector or to the fact that this particular cell line may be inherently difficult to transfect.
促炎细胞因子刺激后人角质形成细胞表达的CC趋化因子配体20(CCL20)受到抑制,可能会减少受体朗格汉斯细胞向组织工程化同种异体皮肤移植物中的迁移,并将受体的免疫排斥反应降至最低。在此,我们在人永生化皮肤角质形成细胞系HaCaT中筛选CCL20基因敲除克隆,并测试多种转染方法以获得最佳效率。
从HaCaT基因组DNA中通过PCR扩增CCL20基因。人CCL20的短臂(1969 bp)和长臂(2356 bp)分别克隆到新霉素抗性盒两侧的ploxP靶向载体中。将得到的ploxP-hCCL20靶向载体线性化并电穿孔导入HaCaT。在G418和GAN C的压力下筛选阳性HaCaT克隆,并通过PCR和Southern印迹进行鉴定。还构建了ploxP-hCCL20-EGFP荧光表达载体,并通过jetPEI脂质体和核转染电穿孔法将其转染到293FT和HaCaT细胞中,以在荧光显微镜下评估转染效率。
成功构建了针对人CCL20基因外显子2的置换靶向载体ploxP-hCCL20(11.9 kb),并将其转染到HaCaT细胞中。通过PCR或Southern印迹分析,所选的HaCaT克隆均未显示出CCL20基因敲除的任何证据。我们还成功构建了荧光表达载体ploxP-hCCL20-EGFP(13.3 kb),以评估基因靶向失败的可能原因。通过jetPEI脂质体将ploxP-hCCL20-EGFP转染到293FT和HaCaT细胞系中的转染效率分别为75.1±3.4%和1.3±0.2%。使用核转染电穿孔法将ploxP-hCCL20-EGFP转染到HaCaT细胞中的转染效率为0.3±0.1%(P = 0.000),但使用相同方法的阳性对照载体pmaxGFP(3490 bp)为38.3±2.8%。
无论采用何种转染方法,ploxP-hCCL20-EGFP转染HaCaT细胞的总体效率较低,这可能是由于载体分子量较大,或者是由于该特定细胞系本身可能难以转染。